CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Nektar Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 17, 2021Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody1
Mar 14, 2018Negatively Biased Sealed Nebulizers Systems And Methods1
Dec 27, 2017Combination-Based Treatment Method1

Top competitors of Nektar Therapeutics

Top competitors of Nektar Therapeutics based on patent oppositions.